Wells Fargo analyst Steve Baxter maintained a Hold rating on HCA Healthcare (HCA – Research Report) yesterday and set a price target of $243.00. The company’s shares closed yesterday at $253.30.
Baxter covers the Healthcare sector, focusing on stocks such as Cigna, HCA Healthcare, and Humana. According to TipRanks, Baxter has an average return of -2.1% and a 57.35% success rate on recommended stocks.
Currently, the analyst consensus on HCA Healthcare is a Strong Buy with an average price target of $279.07.
See today’s best-performing stocks on TipRanks >>
HCA market cap is currently $71.61B and has a P/E ratio of 13.24.
Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1968, HCA Healthcare, Inc. is a healthcare services company, based in Tennessee. The company operates general and psychiatric hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It also offers a full range of services to accommodate medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Read More on HCA:
- HCA Healthcare sees FY23 EPS $16.40-$17.60, consensus $18.23
- HCA Healthcare reports Q4 EPS $4.64, consensus $4.78
- HCA Healthcare price target raised to $296 from $237 at UBS
- HCA Healthcare price target raised to $270 from $240 at Truist
- HCA Healthcare price target raised to $275 from $240 at Deutsche Bank